1887
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.

Rapidly Growing Mycobacteria

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Buy this Microbiology Spectrum Article
Price Non-Member $15.00
  • Authors: Barbara A. Brown-Elliott1, Julie V. Philley2
  • Editor: David Schlossberg3
  • VIEW AFFILIATIONS HIDE AFFILIATIONS
    Affiliations: 1: Department of Microbiology; 2: Department of Medicine, The University of Texas Health Science Center, Tyler, TX 75708; 3: Philadelphia Health Department, Philadelphia, PA
  • Source: microbiolspec January 2017 vol. 5 no. 1 doi:10.1128/microbiolspec.TNMI7-0027-2016
  • Received 04 November 2016 Accepted 09 November 2016 Published 13 January 2017
  • Barbara A. Brown-Elliott, barbara.elliott@uthct.edu
image of Rapidly Growing Mycobacteria
    Preview this microbiology spectrum article:
    Zoom in
    Zoomout

    Rapidly Growing Mycobacteria, Page 1 of 2

    | /docserver/preview/fulltext/microbiolspec/5/1/TNMI7-0027-2016-1.gif /docserver/preview/fulltext/microbiolspec/5/1/TNMI7-0027-2016-2.gif
  • Abstract:

    Rapidly growing mycobacteria (RGM) compose approximately one-half of the currently validated mycobacterial species and are divided into six major groups, including the group, complex, group, group, /, and the pigmented RGM. This review discusses each group and highlights the major types of infections associated with each group. Additionally, phenotypic and molecular laboratory identification methods, including gene sequencing, mass spectrometry, and the newly emerging whole-genome sequencing, are detailed, along with a discussion of the current antimicrobial susceptibility methods and patterns of the most common pathogenic species.

  • Citation: Brown-Elliott B, Philley J. 2017. Rapidly Growing Mycobacteria. Microbiol Spectrum 5(1):TNMI7-0027-2016. doi:10.1128/microbiolspec.TNMI7-0027-2016.

Key Concept Ranking

Tumor Necrosis Factor alpha
0.4333564
Restriction Fragment Length Polymorphism
0.4172795
0.4333564

References

1. Cobbett L. 1918. An acid-fast bacillus obtained from a pustular eruption. BMJ 2:158–159. [PubMed]
2. Moore M, Frerichs JB. 1953. An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp. J Invest Dermatol 20:133–169. [PubMed]
3. da Costa Cruz JC. 1938. Mycobacterium fortuitum: um novo bacilo acido-resistente patogenico para o homen (new acid fast bacillus pathogenic for man). Acta Med Rio Janeiro 1:298–301.
4. Runyon H. 1972. Conservation of the specific epithet fortuitum in the name of the organism known as Mycobacterium fortuitum da Costa Cruz. Int J Syst Bacteriol 22:50–51.
5. Kusunoki S, Ezaki T. 1992. Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. Int J Syst Bacteriol 42:240–245. [PubMed]
6. Schinsky MF, Morey RE, Steigerwalt AG, Douglas MP, Wilson RW, Floyd MM, Butler WR, Daneshvar MI, Brown-Elliott BA, Wallace RJ, Jr, McNeil MM, Brenner DJ, Brown JM. 2004. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol 54:1653–1667. [PubMed]
7. Lourenço Nogueira C, Simmon KE, Chimara E, Cnockaert M, Carlos Palomino J, Martin A, Vandamme P, Brown-Elliott BA, Wallace R, Jr, Cardoso Leão S. 2015. Mycobacterium franklinii sp. nov., a species closely related to members of the Mycobacterium chelonae-Mycobacterium abscessus group. Int J Syst Evol Microbiol 65:2148–2153. [PubMed]
8. Simmon KE, Brown-Elliott BA, Ridge PG, Durtschi JD, Mann LB, Slechta ES, Steigerwalt AG, Moser BD, Whitney AM, Brown JM, Voelkerding KV, McGowan KL, Reilly AF, Kirn TJ, Butler WR, Edelstein PH, Wallace RJ, Jr, Petti CA. 2011. Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA. Emerg Infect Dis 17:1692–1700. [PubMed]
9. Adékambi T, Berger P, Raoult D, Drancourt M. 2006. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. Int J Syst Evol Microbiol 56:133–143. [PubMed]
10. Adékambi T, Drancourt M. 2004. Dissection of phylogenetic relationships among 19 rapidly growing Mycobacterium species by 16S rRNA, hsp65, sodA, recA and rpoB gene sequencing. Int J Syst Evol Microbiol 54:2095–2105. [PubMed]
11. Leao SC, Tortoli E, Viana-Niero C, Ueki SYM, Lima KV, Lopes ML, Yubero J, Menendez MC, Garcia MJ. 2009. Characterization of mycobacteria from a major Brazilian outbreak suggests that revision of the taxonomic status of members of the Mycobacterium chelonae-M. abscessus group is needed. J Clin Microbiol 47:2691–2698. [PubMed]
12. Leao SC, Tortoli E, Euzéby JP, Garcia MJ. 2011. Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus. Int J Syst Evol Microbiol 61:2311–2313. [PubMed]
13. Tortoli E, Kohl TA, Brown-Elliott BA, Trovato A, Cardoso Leao S, Garcia MJ, Vasireddy S, Turenne CY, Griffith DE, Philley JV, Baldan R, Campana S, Cariani L, Colombo C, Taccetti G, Teri A, Niemann S, Wallace RJ, Jr, Cirillo DM, Brown-Elliott BA, Wallace RJ, Jr. 2016. Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus, Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov. Int J Syst Evol Microbiol 66:4471–4479. [PubMed]
14. Kim K, Hong S-H, Kim B-J, Kim B-R, Lee S-Y, Kim G-N, Shim TS, Kook Y-H, Kim B-J. 2015. Separation of Mycobacterium abscessus into subspecies or genotype level by direct application of peptide nucleic acid multi-probe- real-time PCR method into sputa samples. BMC Infect Dis 15:325–331. [PubMed]
15. Tan JL, Ngeow YF, Choo SW. 2015. Support from phylogenomic networks and subspecies signatures for separation of Mycobacterium massiliense from Mycobacterium bolletii. J Clin Microbiol 53:3042–3046. [PubMed]
16. Tettelin H, Davidson RM, Agrawal S, Aitken ML, Shallom S, Hasan NA, Strong M, de Moura VCN, De Groote MA, Duarte RS, Hine E, Parankush S, Su Q, Daugherty SC, Fraser CM, Brown-Elliott BA, Wallace RJ, Jr, Holland SM, Sampaio EP, Olivier KN, Jackson M, Zelazny AM. 2014. High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis 20:364–371. [PubMed]
17. Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, Stock F, Conlan S, McNulty S, Brown-Elliott BA, Wallace RJ, Jr, Olivier KN, Holland SM, Sampaio EP. 2009. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol 47:1985–1995. [PubMed]
18. Brown-Elliott BA, Wallace RJ, Jr. 2015. Mycobacterium: clinical and laboratory characteristics of rapidly growing mycobacteria, p 595–612. In Jorgensen JH, Pfaller MA, Carroll KC, Funke G, Landry ML, Richter SS, Warnock DW (ed), Manual of Clinical Microbiology, 11th Edition. ASM Press, Washington, DC.
19. Brown BA, Springer B, Steingrube VA, Wilson RW, Pfyffer GE, Garcia MJ, Menendez MC, Rodriguez-Salgado B, Jost KC, Jr, Chiu SH, Onyi GO, Böttger EC, Wallace RJ, Jr. 1999. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol 49:1493–1511. [PubMed]
20. Wallace RJ, Jr, Brown-Elliott BA, Wilson RW, Mann L, Hall L, Zhang Y, Jost KC, Jr, Brown JM, Kabani A, Schinsky MF, Steigerwalt AG, Crist CJ, Roberts GD, Blacklock Z, Tsukamura M, Silcox V, Turenne C. 2004. Clinical and laboratory features of Mycobacterium porcinum. J Clin Microbiol 42:5689–5697. [PubMed]
21. Jiménez MS, Campos-Herrero MI, García D, Luquin M, Herrera L, García MJ. 2004. Mycobacterium canariasense sp. nov. Int J Syst Evol Microbiol 54:1729–1734. [PubMed]
22. Whipps CM, Butler WR, Pourahmad F, Watral VG, Kent ML. 2007. Molecular systematics support the revival of Mycobacterium salmoniphilum (ex Ross 1960) sp. nov., nom. rev., a species closely related to Mycobacterium chelonae. Int J Syst Evol Microbiol 57:2525–2531. [PubMed]
23. Brown-Elliott BA, Wallace RJ, Jr. 2002. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15:716–746. [PubMed]
24. Shojaei H, Daley C, Gitti Z, Hashemi A, Heidarieh P, Moore ERB, Naser AD, Russo C, van Ingen J, Tortoli E. 2013. Mycobacterium iranicum sp. nov., a rapidly growing scotochromogenic species isolated from clinical specimens on three different continents. Int J Syst Evol Microbiol 63:1383–1389. [PubMed]
25. Balakrishnan N, Tortoli E, Engel SL, Breitschwerdt EB. 2013. Isolation of a novel strain of Mycobacterium iranicum from a woman in the United States. J Clin Microbiol 51:705–707. [PubMed]
26. Shahraki AH, Çavuşoğlu C, Borroni E, Heidarieh P, Koksalan OK, Cabibbe AM, Hashemzadeh M, Mariottini A, Mostafavi E, Cittaro D, Feizabadi MM, Lazarevic D, Yaghmaei F, Molinari GL, Camaggi A, Tortoli E. 2015. Mycobacterium celeriflavum sp. nov., a rapidly growing scotochromogenic bacterium isolated from clinical specimens. Int J Syst Evol Microbiol 65:510–515. [PubMed]
27. Brown-Elliott BA, Wallace RJ, Jr, Petti CA, Mann LB, McGlasson M, Chihara S, Smith GL, Painter P, Hail D, Wilson R, Simmon KE. 2010. Mycobacterium neoaurum and Mycobacterium bacteremicum sp. nov. as causes of mycobacteremia. J Clin Microbiol 48:4377–4385. [PubMed]
28. Hennessee CT, Seo J-S, Alvarez AM, Li QX. 2009. Polycyclic aromatic hydrocarbon-degrading species isolated from Hawaiian soils: Mycobacterium crocinum sp. nov., Mycobacterium pallens sp. nov., Mycobacterium rutilum sp. nov., Mycobacterium rufum sp. nov. and Mycobacterium aromaticivorans sp. nov. Int J Syst Evol Microbiol 59:378–387. [PubMed]
29. Tortoli E. 2003. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 16:319–354. [PubMed]
30. Tortoli E. 2006. The new mycobacteria: an update. FEMS Immunol Med Microbiol 48:159–178. [PubMed]
31. Adékambi T, Reynaud-Gaubert M, Greub G, Gevaudan MJ, La Scola B, Raoult D, Drancourt M. 2004. Amoebal coculture of “Mycobacterium massiliense” sp. nov. from the sputum of a patient with hemoptoic pneumonia. J Clin Microbiol 42:5493–5501. [PubMed]
32. Gomila M, Ramirez A, Gascó J, Lalucat J. 2008. Mycobacterium llatzerense sp. nov., a facultatively autotrophic, hydrogen-oxidizing bacterium isolated from haemodialysis water. Int J Syst Evol Microbiol 58:2769–2773. [PubMed]
33. Lamy B, Marchandin H, Hamitouche K, Laurent F. 2008. Mycobacterium setense sp. nov., a Mycobacterium fortuitum-group organism isolated from a patient with soft tissue infection and osteitis. Int J Syst Evol Microbiol 58:486–490. [PubMed]
34. Sahraoui N, Ballif M, Zelleg S, Yousfi N, Ritter C, Friedel U, Amstutz B, Yala D, Boulahbal F, Guetarni D, Zinsstag J, Keller PM. 2011. Mycobacterium algericum sp. nov., a novel rapidly growing species related to the Mycobacterium terrae complex and associated with goat lung lesions. Int J Syst Evol Microbiol 61:1870–1874. [PubMed]
35. Guérin-Faublée V, Flandrois J-P, Pichat C, Boschiroli ML, Lamy B. 2013. Mycobacterium bourgelatii sp. nov., a rapidly growing, non-chromogenic species isolated from the lymph nodes of cattle. Int J Syst Evol Microbiol 63:4669–4674. [PubMed]
36. Balcázar JL, Planas M, Pintado J. 2014. Mycobacterium hippocampi sp. nov., a rapidly growing scotochromogenic species isolated from a seahorse with tail rot. Curr Microbiol 69:329–333. [PubMed]
37. Kim B-J, Kim JM, Kim B-R, Lee S-Y, Kim G, Jang Y-H, Ryoo S, Jeon C-O, Jin H-M, Jeong J, Lee S-H, Lim J-H, Kook Y-H, Kim B-J. 2015. Mycobacterium anyangense sp. nov., a rapidly growing species isolated from blood of Korean native cattle, Hanwoo (Bos taurus coreanae). Int J Syst Evol Microbiol 65:2277–2285. [PubMed]
38. Zhang D-F, Chen X, Zhang X-M, Zhi X-Y, Yao J-C, Jiang Y, Xiong Z, Li W-J. 2013. Mycobacterium sediminis sp. nov. and Mycobacterium arabiense sp. nov., two rapidly growing members of the genus Mycobacterium. Int J Syst Evol Microbiol 63:4081–4086. [PubMed]
39. Zhang Y, Zhang J, Fang C, Pang H, Fan J. 2012. Mycobacterium litorale sp. nov., a rapidly growing mycobacterium from soil. Int J Syst Evol Microbiol 62:1204–1207. [PubMed]
40. Falkinham JO. 2003. The changing pattern of nontuberculous mycobacterial disease. Can J Infect Dis 14:281–286. [PubMed]
41. Wolinsky E. 1979. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119:107–159. [PubMed]
42. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416. [PubMed]
43. Cooksey RC, de Waard JH, Yakrus MA, Rivera I, Chopite M, Toney SR, Morlock GP, Butler WR. 2004. Mycobacterium cosmeticum sp. nov., a novel rapidly growing species isolated from a cosmetic infection and from a nail salon. Int J Syst Evol Microbiol 54:2385–2391. [PubMed]
44. Gira AK, Reisenauer AH, Hammock L, Nadiminti U, Macy JT, Reeves A, Burnett C, Yakrus MA, Toney S, Jensen BJ, Blumberg HM, Caughman SW, Nolte FS. 2004. Furunculosis due to Mycobacterium mageritense associated with footbaths at a nail salon. J Clin Microbiol 42:1813–1817. [PubMed]
45. Winthrop KL, Albridge K, South D, Albrecht P, Abrams M, Samuel MC, Leonard W, Wagner J, Vugia DJ. 2004. The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection. Clin Infect Dis 38:38–44. [PubMed]
46. Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. 2009. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 15:1556–1561. [PubMed]
47. Valour F, Perpoint T, Sénéchal A, Kong X-F, Bustamante J, Ferry T, Chidiac C, Ader F, Lyon TB Study Group. 2016. Interferon-γ autoantibodies as predisposing factor for nontuberculous mycobacterial infection. Emerg Infect Dis 22:1124–1126. [PubMed]
48. Czaja CA, Merkel PA, Chan ED, Lenz LL, Wolf ML, Alam R, Frankel SK, Fischer A, Gogate S, Perez-Velez CM, Knight V. 2014. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody. Clin Infect Dis 58:e115–e118. [PubMed]
49. Havlir DV, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC, Jr, Witt MD, Bozzette SA, McCutchan JA, California Collaborative Treatment Group. 1996. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N Engl J Med 335:392–398. [PubMed]
50. Covert TC, Rodgers MR, Reyes AL, Stelma GN, Jr. 1999. Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol 65:2492–2496. [PubMed]
51. Phillips MS, von Reyn CF. 2001. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis 33:1363–1374. [PubMed]
52. Gubler JGH, Salfinger M, von Graevenitz A. 1992. Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine. Report of an outbreak and review of the literature. Chest 101:1245–1249.
53. Tiwari TSP, Ray B, Jost KC, Jr, Rathod MK, Zhang Y, Brown-Elliott BA, Hendricks K, Wallace RJ, Jr. 2003. Forty years of disinfectant failure: outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride. Clin Infect Dis 36:954–962. [PubMed]
54. Carson LA, Bland LA, Cusick LB, Favero MS, Bolan GA, Reingold AL, Good RC. 1988. Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol 54:3122–3125. [PubMed]
55. Schulze-Röbbecke R, Janning B, Fischeder R. 1992. Occurrence of mycobacteria in biofilm samples. Tuber Lung Dis 73:141–144. [PubMed]
56. Galassi L, Donato R, Tortoli E, Burrini D, Santianni D, Dei R. 2003. Nontuberculous mycobacteria in hospital water systems: application of HPLC for identification of environmental mycobacteria. J Water Health 1:133–139. [PubMed]
57. Hector JSR, Pang Y, Mazurek GH, Zhang Y, Brown BA, Wallace RJ, Jr. 1992. Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J Clin Microbiol 30:1250–1255. [PubMed]
58. Zhang Y, Rajagopalan M, Brown BA, Wallace RJ, Jr. 1997. Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks. J Clin Microbiol 35:3132–3139. [PubMed]
59. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. 2007. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis 45:687–694. [PubMed]
60. Lai KK, Brown BA, Westerling JA, Fontecchio SA, Zhang Y, Wallace RJ, Jr. 1998. Long-term laboratory contamination by Mycobacterium abscessus resulting in two pseudo-outbreaks: recognition with use of random amplified polymorphic DNA (RAPD) polymerase chain reaction. Clin Infect Dis 27:169–175. [PubMed]
61. Villanueva A, Calderon RV, Vargas BA, Ruiz F, Aguero S, Zhang Y, Brown BA, Wallace RJ, Jr. 1997. Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis 24:1147–1153. [PubMed]
62. Zhibang Y, BiXia Z, Qishan L, Lihao C, Xiangquan L, Huaping L. 2002. Large-scale outbreak of infection with Mycobacterium chelonae subsp. abscessus after penicillin injection. J Clin Microbiol 40:2626–2628. [PubMed]
63. Kim H-Y, Yun Y-J, Park CG, Lee DH, Cho YK, Park BJ, Joo S-I, Kim E-C, Hur YJ, Kim B-J, Kook YH. 2007. Outbreak of Mycobacterium massiliense infection associated with intramuscular injections. J Clin Microbiol 45:3127–3130. [PubMed]
64. Galil K, Miller LA, Yakrus MA, Wallace RJ, Jr, Mosley DG, England B, Huitt G, McNeil MM, Perkins BA. 1999. Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis 5:681–687. [PubMed]
65. Cooksey RC, Jhung MA, Yakrus MA, Butler WR, Adékambi T, Morlock GP, Williams M, Shams AM, Jensen BJ, Morey RE, Charles N, Toney SR, Jost KC, Jr, Dunbar DF, Bennett V, Kuan M, Srinivasan A. 2008. Multiphasic approach reveals genetic diversity of environmental and patient isolates of Mycobacterium mucogenicum and Mycobacterium phocaicum associated with an outbreak of bacteremias at a Texas hospital. Appl Environ Microbiol 74:2480–2487. [PubMed]
66. Centers for Disease Control and Prevention. 1998. Rapidly growing mycobacterial infection following liposuction and liposculpture—Caracas, Venezuela, 1996–1998. MMWR Morb Mortal Wkly Rep 47:1065–1067. [PubMed]
67. Centers for Disease Control and Prevention. 2004. Nontuberculous mycobacterial infections after cosmetic surgery—Santo Domingo, Dominican Republic, 2003–2004. MMWR Morb Mortal Wkly Rep 53:509. [PubMed]
68. Del-Castillo M, Palmero D, Lopez B, Paul R, Ritacco V, Bonvehi P, Clara L, Ambroggi M, Barrera L, Vay C. 2009. Mesotherapy-associated outbreak caused by Mycobacterium immunogenum. Emerg Infect Dis 15:357–359. [PubMed]
69. Meyers H, Brown-Elliott BA, Moore D, Curry J, Truong C, Zhang Y, Wallace RJ, Jr. 2002. An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis 34:1500–1507. [PubMed]
70. Regnier S, Cambau E, Meningaud JP, Guihot A, Deforges L, Carbonne A, Bricaire F, Caumes E. 2009. Clinical management of rapidly growing mycobacterial cutaneous infections in patients after mesotherapy. Clin Infect Dis 49:1358–1364. [PubMed]
71. Sampaio JL, Chimara E, Ferrazoli L, da Silva Telles MA, Del Guercio VM, Jericó ZV, Miyashiro K, Fortaleza CM, Padoveze MC, Leão SC. 2006. Application of four molecular typing methods for analysis of Mycobacterium fortuitum group strains causing post-mammaplasty infections. Clin Microbiol Infect 12:142–149. [PubMed]
72. van Dissel JT, Kuijper EJ. 2009. Rapidly growing mycobacteria: emerging pathogens in cosmetic procedures of the skin. Clin Infect Dis 49:1365–1368. [PubMed]
73. Furuya EY, Paez A, Srinivasan A, Cooksey R, Augenbraun M, Baron M, Brudney K, Della-Latta P, Estivariz C, Fischer S, Flood M, Kellner P, Roman C, Yakrus M, Weiss D, Granowitz EV. 2008. Outbreak of Mycobacterium abscessus wound infections among “lipotourists” from the United States who underwent abdominoplasty in the Dominican Republic. Clin Infect Dis 46:1181–1188. [PubMed]
74. Falsey RR, Kinzer MH, Hurst S, Kalus A, Pottinger PS, Duchin JS, Zhang J, Noble-Wang J, Shinohara MM. 2013. Cutaneous inoculation of nontuberculous mycobacteria during professional tattooing: a case series and epidemiologic study. Clin Infect Dis 57:e143–e147. [PubMed]
75. Culton DA, Lachiewicz AM, Miller BA, Miller MB, Mackuen C, Groben P, White B, Cox GM, Stout JE. 2013. Nontuberculous mycobacterial infection after fractionated CO(2) laser resurfacing. Emerg Infect Dis 19:365–370. [PubMed]
76. Ivan M, Dancer C, Koehler AP, Hobby M, Lease C. 2013. Mycobacterium chelonae abscesses associated with biomesotherapy, Australia, 2008. Emerg Infect Dis 19:1493–1495. [PubMed]
77. Woo PCY, Leung K-W, Wong SSY, Chong KTK, Cheung EYL, Yuen K-Y. 2002. Relatively alcohol-resistant mycobacteria are emerging pathogens in patients receiving acupuncture treatment. J Clin Microbiol 40:1219–1224. [PubMed]
78. Viana-Niero C, Lima KVB, Lopes ML, Rabello MC, Marsola LR, Brilhante VCR, Durham AM, Leão SC. 2008. Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures. J Clin Microbiol 46:850–855. [PubMed]
79. Vugia DJ, Jang Y, Zizek C, Ely J, Winthrop KL, Desmond E. 2005. Mycobacteria in nail salon whirlpool footbaths, California. Emerg Infect Dis 11:616–618. [PubMed]
80. Duarte RS, Lourenço MC, Fonseca LS, Leão SC, Amorim EL, Rocha IL, Coelho FS, Viana-Niero C, Gomes KM, da Silva MG, Lorena NS, Pitombo MB, Ferreira RM, Garcia MH, de Oliveira GP, Lupi O, Vilaça BR, Serradas LR, Chebabo A, Marques EA, Teixeira LM, Dalcolmo M, Senna SG, Sampaio JL. 2009. Epidemic of postsurgical infections caused by Mycobacterium massiliense. J Clin Microbiol 47:2149–2155. [PubMed]
81. Matsumoto CK, Chimara E, Ramos JP, Campos CED, De Suza Caldas PC, Lima KVB, Lopes ML, Duarte RS, Leão SC. 2012. Rapid tests for the detection of the Mycobacterium abscessus subsp. bolletii strain responsible for an epidemic of surgical-site infections in Brazil. Mem Inst Oswaldo Cruz 107:969–970. [PubMed]
82. Wilson RW, Steingrube VA, Böttger EC, Springer B, Brown-Elliott BA, Vincent V, Jost KC Jr, Zhang Y, Garcia MJ, Chiu SH, Onyi GO, Rossmoore H, Nash DR, Wallace RJ, Jr. 2001. Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol 51:1751–1764. [PubMed]
83. Nagpal A, Wentink JE, Berbari EF, Aronhalt KC, Wright AJ, Krageschmidt DA, Wengenack NL, Thompson RL, Tosh PK. 2014. A cluster of Mycobacterium wolinskyi surgical site infections at an academic medical center. Infect Control Hosp Epidemiol 35:1169–1175. [PubMed]
84. Dupont C, Terru D, Aguilhon S, Frapier J-M, Paquis M-P, Morquin D, Lamy B, Godreuil S, Parer S, Lotthé A, Jumas-Bilak E, Romano-Bertrand S. 2016. Source-case investigation of Mycobacterium wolinskyi cardiac surgical site infection. J Hosp Infect 93:235–239. [PubMed]
85. Baker AW, Lewis SS, Alexander BD, Isaacs PJ, Pickett LC, Wallace RJ, Jr, Brown-Elliott BA, Strittholt N, Hazen KC, Wolfe CR, Maziarz EK, Saullo JH, Davis RD, Reynolds JM, Anderson D, Sexton DJ, Chen LF. 2015. A cluster of Mycobacterium abscessus among lung transplant patients: investigation and mitigation. Open Forum Infect Dis doi:10.1093/ofid/ofv131.50.
86. Tortoli E. 2014. Microbiological features and clinical relevance of new species of the genus Mycobacterium. Clin Microbiol Rev 27:727–752. [PubMed]
87. Steingrube VA, Gibson JL, Brown BA, Zhang Y, Wilson RW, Rajagopalan M, Wallace RJ, Jr. 1995. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol 33:149–153. (Erratum, 33:1686.)
88. Telenti A, Marchesi F, Balz M, Bally F, Böttger EC, Bodmer T. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 31:175–178. [PubMed]
89. Turenne CY, Tschetter L, Wolfe J, Kabani A. 2001. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol 39:3637–3648. [PubMed]
90. Clinical and Laboratory Standards Institute. 2007. Interpretive Criteria for Microorganism Identification by DNA Target Sequencing. Proposed guideline. CLSI document MM18-P. Clinical and Laboratory Standards Institute, Wayne, PA.
91. Forbes BA, Banaiee N, Beavis KG, Brown-Elliott BA, Della Latta P, Elliott LB, Hall GS, Hanna B, Perkins MD, Siddiqi SH, Wallace RJ, Jr, Warren NG. 2008. Laboratory Detection and Identification of Mycobacteria. Approved guideline. CLSI document M48-A. Clinical and Laboratory Standards Institute, Wayne, PA.
92. McNabb A, Eisler D, Adie K, Amos M, Rodrigues M, Stephens G, Black WA, Isaac-Renton J. 2004. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources. J Clin Microbiol 42:3000–3011. [PubMed]
93. Adékambi T, Colson P, Drancourt M. 2003. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol 41:5699–5708. [PubMed]
94. Kim H-Y, Kook Y, Yun Y-J, Park CG, Lee NY, Shim TS, Kim B-J, Kook Y-H. 2008. Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. J Clin Microbiol 46:3384–3390. [PubMed]
95. Macheras E, Roux A-L, Ripoll F, Sivadon-Tardy V, Gutierrez C, Gaillard J-L, Heym B. 2009. Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. J Clin Microbiol 47:2596–2600. [PubMed]
96. Tortoli E, Nanetti A, Piersimoni C, Cichero P, Farina C, Mucignat G, Scarparo C, Bartolini L, Valentini R, Nista D, Gesu G, Tosi CP, Crovatto M, Brusarosco G. 2001. Performance assessment of new multiplex probe assay for identification of mycobacteria. J Clin Microbiol 39:1079–1084. [PubMed]
97. Tortoli E, Pecorari M, Fabio G, Messinò M, Fabio A. 2010. Commercial DNA probes for mycobacteria incorrectly identify a number of less frequently encountered species. J Clin Microbiol 48:307–310. [PubMed]
98. Richter E, Rüsch-Gerdes S, Hillemann D. 2006. Evaluation of the GenoType Mycobacterium assay for identification of mycobacterial species from cultures. J Clin Microbiol 44:1769–1775. [PubMed]
99. Buckwalter SP, Olson SL, Connelly BJ, Lucas BC, Rodning AA, Walchak RC, Deml SM, Wohlfiel SL, Wengenack NL. 2016. Evaluation of matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of Mycobacterium species, Nocardia species, and other aerobic actinomycetes. J Clin Microbiol 54:376–384. [PubMed]
100. Saleeb PG, Drake SK, Murray PR, Zelazny AM. 2011. Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 49:1790–1794. [PubMed]
101. Rodríguez-Sánchez B, Ruiz-Serrano MJ, Ruiz A, Timke M, Kostrzewa M, Bouza E. 2016. Evaluation of MALDI biotyper mycobacterial library v3.0 for identification of nontuberculous mycobacteria. J Clin Microbiol 54:1144–1147. [PubMed]
102. Wilen CB, McMullen AR, Burnham C-AD. 2015. Comparison of sample preparation methods, instrumentation platforms, and contemporary commercial databases for identification of clinically relevant mycobacteria by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 53:2308–2315. [PubMed]
103. Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, Inns T, Reacher M, Haworth CS, Curran MD, Harris SR, Peacock SJ, Parkhill J, Floto RA. 2013. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 381:1551–1560.
104. Davidson RM, Hasan NA, Reynolds PR, Totten S, Garcia B, Levin A, Ramamoorthy P, Heifets L, Daley CL, Strong M. 2014. Genome sequencing of Mycobacterium abscessus isolates from patients in the United States and comparisons to globally diverse clinical strains. J Clin Microbiol 52:3573–3582. [PubMed]
105. Ngeow YF, Wee WY, Wong YL, Tan JL, Ongi CS, Ng KP, Choo SW. 2012. Genomic analysis of Mycobacterium abscessus strain M139, which has an ambiguous subspecies taxonomic position. J Bacteriol 194:6002–6003. [PubMed]
106. Ngeow YF, Wong YL, Lokanathan N, Wong GJ, Ong CS, Ng KP, Choo SW. 2012. Genomic analysis of Mycobacterium massiliense strain M115, an isolate from human sputum. J Bacteriol 194:4786. [PubMed]
107. Ngeow YF, Wong YL, Tan JL, Arumugam R, Wong GJ, Ong CS, Ng KP, Choo SW. 2012. Genome sequence of Mycobacterium massiliense M18, isolated from a lymph node biopsy specimen. J Bacteriol 194:4125. [PubMed]
108. Choo SW, Wong YL, Tan JL, Ong CS, Wong GJ, Ng KP, Ngeow YF. 2012. Annotated genome sequence of Mycobacterium massiliense strain M154, belonging to the recently created taxon Mycobacterium abscessus subsp. bolletii comb. nov. J Bacteriol 194:4778. [PubMed]
109. Tettelin H, Sampaio EP, Daugherty SC, Hine E, Riley DR, Sadzewicz L, Sengamalay N, Shefchek K, Su Q, Tallon LJ, Conville P, Olivier KN, Holland SM, Fraser CM, Zelazny AM. 2012. Genomic insights into the emerging human pathogen Mycobacterium massiliense. J Bacteriol 194:5450. [PubMed]
110. Chan J, Halachev M, Yates E, Smith G, Pallen M. 2012. Whole-genome sequence of the emerging pathogen Mycobacterium abscessus strain 47J26. J Bacteriol 194:549. [PubMed]
111. Wallace RJ, Jr, Brown-Elliott BA, Brown J, Steigerwalt AG, Hall L, Woods G, Cloud J, Mann L, Wilson R, Crist C, Jost KC, Jr, Byrer DE, Tang J, Cooper J, Stamenova E, Campbell B, Wolfe J, Turenne C. 2005. Polyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalense. J Clin Microbiol 43:5925–5935. [PubMed]
112. Wallace RJ, Jr, Brown-Elliott BA, Hall L, Roberts G, Wilson RW, Mann LB, Crist CJ, Chiu SH, Dunlap R, Garcia MJ, Bagwell JT, Jost KC, Jr. 2002. Clinical and laboratory features of Mycobacterium mageritense. J Clin Microbiol 40:2930–2935. [PubMed]
113. Clinical and Laboratory Standards Institute. 2011. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes. Approved standard, 2nd ed. CLSI document M24-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
114. Wallace RJ, Jr, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. 2002. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 46:3164–3167. [PubMed]
115. Brown BA, Wallace RJ, Jr, Onyi GO, De Rosas V, Wallace RJ, III. 1992. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 36:180–184. [PubMed]
116. Nash KA. 2003. Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38). Antimicrob Agents Chemother 47:3053–3060. [PubMed]
117. Nash KA, Andini N, Zhang Y, Brown-Elliott BA, Wallace RJ, Jr. 2006. Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother 50:3476–3478. [PubMed]
118. Nash KA, Brown-Elliott BA, Wallace RJ, Jr. 2009. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 53:1367–1376. [PubMed]
119. Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ, Jr. 2005. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother 55:170–177. [PubMed]
120. Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST, Nash KA, Parodi N, Strong A, Gee M, Smith T, Wallace RJ, Jr. 2015. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. J Clin Microbiol 53:1211–1215. (Erratum, 54:1172, 2016.)
121. Brown-Elliott BA, Hanson K, Vasireddy S, Iakhiaeva E, Nash KA, Vasireddy R, Parodi N, Smith T, Gee M, Strong A, Barker A, Cohen S, Muir H, Slechta ES, Wallace RJ, Jr. 2015. Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility. J Clin Microbiol 53:875–878. [PubMed]
122. Koh WJ, Jeon K, Lee NY, Kim B-J, Kook Y-H, Lee S-H, Park Y-K, Kim CK, Shin SJ, Huitt GA, Daley CL, Kwon OJ. 2011. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 183:405–410. [PubMed]
123. Olivier KN, Griffith DE, Eagle G, McGinnis Ii JP, Micioni L, Liu K, Daley CL, Winthrop KL, Ruoss S, Addrizzo-Harris DJ, Flume PA, Dorgan D, Salathe M, Brown-Elliott BA, Gupta R, Wallace RJ, Jr. 17 October 2016. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease. Am J Respir Crit Care Med doi:10.1164/rccm.201604-0700OC.
124. Brown-Elliott BA, Iakhiaeva E, Griffith DE, Woods GL, Stout JE, Wolfe CR, Turenne CY, Wallace RJ, Jr. 2013. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. J Clin Microbiol 51:3389–3394. (Erratum, 52:1311, 2014.) [PubMed]
125. Wallace RJ, Jr, Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW. 2001. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 45:764–767. [PubMed]
126. Brown-Elliott BA, Wallace RJ, Jr, Blinkhorn R, Crist CJ, Mann LB. 2001. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 33:1433–1434. [PubMed]
127. Brown-Elliott BA, Philley JV, Griffith DE, Wallace RJ, Jr. 2016. Comparison of in vitro susceptibility testing of tedizolid (TZD) and linezolid (LZD) against isolates of nontuberculous mycobacteria (NTM). ASM Microbe 2016, Boston, MA. http://gm.asm.org/.
128. Wallace RJ, Jr, Dukart G, Brown-Elliott BA, Griffith DE, Scerpella EG, Marshall B. 2014. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. J Antimicrob Chemother 69:1945–1953. [PubMed]
129. Shen G-H, Wu B-D, Hu S-T, Lin C-F, Wu K-M, Chen J-H. 2010. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria. Int J Antimicrob Agents 35:400–404. [PubMed]
130. van Ingen J, Boeree MJ, van Soolingen D, Mouton JW. 2012. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat 15:149–161. [PubMed]
131. Philley JV, Wallace RJ, Jr, Benwill JL, Taskar V, Brown-Elliott BA, Thakkar F, Aksamit TR, Griffith DE. 2015. Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease. Chest 148:499–506. [PubMed]
132. Maurer FP, Bruderer VL, Ritter C, Castelberg C, Bloemberg GV, Böttger EC. 2014. Lack of antimicrobial bactericidal activity in Mycobacterium abscessus. Antimicrob Agents Chemother 58:3828–3836. [PubMed]
133. Sudesh S, Cohen EJ, Schwartz LW, Myers JS. 2000. Mycobacterium chelonae infection in a corneal graft. Arch Ophthalmol 118:294–295. [PubMed]
134. Reviglio V, Rodriguez ML, Picotti GS, Paradello M, Luna JD, Juárez CP. 1998. Mycobacterium chelonae keratitis following laser in situ keratomileusis. J Refract Surg 14:357–360. [PubMed]
135. Saluja A, Peters NT, Lowe L, Johnson TM. 1997. A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. Dermatol Surg 23:539–543. [PubMed]
136. Friedman ND, Sexton DJ. 2001. Bursitis due to Mycobacterium goodii, a recently described, rapidly growing mycobacterium. J Clin Microbiol 39:404–405. [PubMed]
137. Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. 2011. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis 71:421–427. [PubMed]
138. Bossart S, Schnell B, Kerl K, Urosevic-Maiwald M. 2016. Ulcers as a sign of skin infection with Mycobacterium wolinskyi: report of a case and review of the literature. Case Rep Dermatol 8:151–155. [PubMed]
139. Peralta G, Tobin-D’Angelo M, Parham A, Edison L, Lorentzson L, Smith C, Drenzek C. 2016. Notes from the field: Mycobacterium abscessus infections among patients of a pediatric dentistry practice—Georgia, 2015. MMWR Morb Mortal Wkly Rep 65:355–356. [PubMed]
140. Raad II, Vartivarian S, Khan A, Bodey GP. 1991. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 13:1120–1125. [PubMed]
141. Washer LL, Riddell J, IV, Rider J, Chenoweth CE. 2007. Mycobacterium neoaurum bloodstream infection: report of 4 cases and review of the literature. Clin Infect Dis 45:e10–e13. [PubMed]
142. Martínez López AB, Álvarez Blanco O, Ruíz Serrano MJ, Morales San-José MD, Luque de Pablos A. 2015. Mycobacterium fortuitum as a cause of peritoneal dialysis catheter port infection. A clinical case and a review of the literature. Nefrologia 35:584–586. [PubMed]
143. Al Shaalan M, Law BJ, Israels SJ, Pianosi P, Lacson AG, Higgins R. 1997. Mycobacterium fortuitum interstitial pneumonia with vasculitis in a child with Wilms’ tumor. Pediatr Infect Dis J 16:996–1000. [PubMed]
144. Levendoglu-Tugal O, Munoz J, Brudnicki A, Fevzi Ozkaynak M, Sandoval C, Jayabose S. 1998. Infections due to nontuberculous mycobacteria in children with leukemia. Clin Infect Dis 27:1227–1230. [PubMed]
145. Tahara M, Yatera K, Yamasaki K, Orihashi T, Hirosawa M, Ogoshi T, Noguchi S, Nishida C, Ishimoto H, Yonezawa A, Tsukada J, Mukae H. 2016. Disseminated Mycobacterium abscessus complex infection manifesting as multiple areas of lymphadenitis and skin abscess in the preclinical stage of acute lymphocytic leukemia. Intern Med 55:1787–1791. [PubMed]
146. Chetchotisakd P, Mootsikapun P, Anunnatsiri S, Jirarattanapochai K, Choonhakarn C, Chaiprasert A, Ubol PN, Wheat LJ, Davis TE. 2000. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin Infect Dis 30:29–34. [PubMed]
147. McShane PJ, Glassroth J. 2015. Pulmonary disease due to nontuberculous mycobacteria: current state and new insights. Chest 148:1517–1527. [PubMed]
148. Matsumoto T, Otsuka K, Tomii K. 2015. Mycobacterium fortuitum thoracic empyema: a case report and review of the literature. J Infect Chemother 21:747–750. [PubMed]
149. Cullen AR, Cannon CL, Mark EJ, Colin AA. 2000. Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection? Am J Respir Crit Care Med 161:641–645. [PubMed]
150. Fauroux B, Delaisi B, Clément A, Saizou C, Moissenet D, Truffot-Pernot C, Tournier G, Vu Thien H. 1997. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J 16:354–358. [PubMed]
151. Olivier KN, Weber DJ, Wallace RJ, Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR, Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. 2003. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167:828–834. [PubMed]
152. Bange F-C, Brown BA, Smaczny C, Wallace RJ, Jr, Böttger EC. 2001. Lack of transmission of Mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin Infect Dis 32:1648–1650. [PubMed]
153. Aitken ML, Limaye A, Pottinger P, Whimbey E, Goss CH, Tonelli MR, Cangelosi GA, Dirac MA, Olivier KN, Brown-Elliott BA, McNulty S, Wallace RJ, Jr. 2012. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med 185:231–232. [PubMed]
154. Roux A-L, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, Bellis G, Vibet M-A, Le Roux E, Lemonnier L, Gutierrez C, Vincent V, Fauroux B, Rottman M, Guillemot D, Gaillard J-L, Herrmann J-L, the OMA Group. 2009. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. J Clin Microbiol 47:4124–4128. [PubMed]
155. Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, Chiron R, Fauroux B, Le Bourgeois M, Munck A, Pin I, Sermet I, Gutierrez C, Véziris N, Jarlier V, Cambau E, Herrmann JL, Guillemot D, Gaillard JL, OMA Group. 2015. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. J Cyst Fibros 14:63–69. [PubMed]
156. Cândido PHC, Nunes LS, Marques EA, Folescu TW, Coelho FS, de Moura VC, da Silva MG, Gomes KM, Lourenço MC, Aguiar FS, Chitolina F, Armstrong DT, Leão SC, Neves FPG, Mello FC, Duarte RS. 2014. Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients. J Clin Microbiol 52:2990–2997. [PubMed]
157. Jönsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C. 2007. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol 45:1497–1504. [PubMed]
158. Flor A, Capdevila JA, Martin N, Gavaldà J, Pahissa A. 1996. Nontuberculous mycobacterial meningitis: report of two cases and review. Clin Infect Dis 23:1266–1273. [PubMed]
159. Wallace RJ, Jr. 2004. Infections due to nontuberculous mycobacteria, p 461–478. In Scheld WM, Whitley RJ, Marra CM (ed), Infections of the Central Nervous System, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, PA. [PubMed]
160. Levy ZD, Du V, Chiluwal A, Chalif DJ, Ledoux DE. 2016. Ventriculoperitoneal shunt infection with Mycobacterium abscessus: a rare cause of ventriculitis. World Neurosurg 86:510.e1–510.e4. [PubMed]
161. Benwill JL, Philley JV, Taskar V, Brown-Elliott BA, Griffith DE, Wallace RJ, Jr. 2014. Inhaled amikacin for the treatment of pulmonary Mycobacterium avium complex (MAC) infection, abstr A4112. ATS 2014 International Conference.
162. Lee M-R, Cheng A, Lee Y-C, Yang C-Y, Lai C-C, Huang Y-T, Ho C-C, Wang H-C, Yu C-J, Hsueh P-R. 2012. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. J Antimicrob Chemother 67:222–225. [PubMed]
163. Brown-Elliott BA, Mann LB, Hail D, Whitney C, Wallace RJ, Jr. 2012. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections. Cornea 31:900–906. [PubMed]
164. Al Kheraiji NF, Al Kheraiji AF, Stone DU. 23 August 2016. Mycobacterium abscessus scleritis after a Baerveldt glaucoma implant. Clin Exp Ophthalmol doi:10.1111/ceo.12824. [PubMed]
165. Shah M, Relhan N, Kuriyan AE, Davis JL, Albini TA, Pathengay A, Miller D, Flynn HW, Jr. 2016. Endophthalmitis caused by nontuberculous Mycobacterium: clinical features, antimicrobial susceptibilities, and treatment outcomes. Am J Ophthalmol 168:150–156. [PubMed]
166. Kheir WJ, Sheheitli H, Abdul Fattah M, Hamam RN. 2015. Nontuberculous mycobacterial ocular infections: a systematic review of the literature. BioMed Res Int 2015:164989. [PubMed]
167. Wallace RJ, Jr, Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, Böttger EC. 1996. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 40:1676–1681. [PubMed]
168. Koh WJ, Stout JE, Yew WW. 2014. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex. Int J Tuberc Lung Dis 18:1141–1148. [PubMed]
169. Koh WJ, Jeong BH, Jeon K, Kim SY, Park KU, Park HY, Huh HJ, Ki CS, Lee NY, Lee SH, Kim CK, Daley CL, Shin SJ, Kim H, Kwon OJ. 2016. Oral macrolide therapy following short-term combination antibiotic treatment for Mycobacterium massiliense lung disease. Chest 2016:S0012-3692(16)48970-1.
microbiolspec.TNMI7-0027-2016.citations
cm/5/1
content/journal/microbiolspec/10.1128/microbiolspec.TNMI7-0027-2016
Loading

Citations loading...

Loading

Article metrics loading...

/content/journal/microbiolspec/10.1128/microbiolspec.TNMI7-0027-2016
2017-01-13
2017-09-23

Abstract:

Rapidly growing mycobacteria (RGM) compose approximately one-half of the currently validated mycobacterial species and are divided into six major groups, including the group, complex, group, group, /, and the pigmented RGM. This review discusses each group and highlights the major types of infections associated with each group. Additionally, phenotypic and molecular laboratory identification methods, including gene sequencing, mass spectrometry, and the newly emerging whole-genome sequencing, are detailed, along with a discussion of the current antimicrobial susceptibility methods and patterns of the most common pathogenic species.

Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Tables

Generic image for table
TABLE 1

Currently recognized species of RGM

Source: microbiolspec January 2017 vol. 5 no. 1 doi:10.1128/microbiolspec.TNMI7-0027-2016
Generic image for table
TABLE 2

Antimicrobials used for treatment of commonly encountered species of RGM

Source: microbiolspec January 2017 vol. 5 no. 1 doi:10.1128/microbiolspec.TNMI7-0027-2016
Generic image for table
TABLE 3

General principles of therapy of RGM disease

Source: microbiolspec January 2017 vol. 5 no. 1 doi:10.1128/microbiolspec.TNMI7-0027-2016
Generic image for table
TABLE 4

Species or taxonomic group and their common clinical settings

Source: microbiolspec January 2017 vol. 5 no. 1 doi:10.1128/microbiolspec.TNMI7-0027-2016
Generic image for table
TABLE 5

Pulmonary syndromes associated with respiratory cultures positive for RGM

Source: microbiolspec January 2017 vol. 5 no. 1 doi:10.1128/microbiolspec.TNMI7-0027-2016

Supplemental Material

No supplementary material available for this content.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error